Executive Summary
Overnight filings reveal a market bifurcated between aggressive insider buying at micro-cap biotech Quoin Pharmaceuticals and significant insider selling at high-growth industrials like Coherent and Standex, signaling divergent management conviction. The most material corporate event is the termination of the Quantumsphere Acquisition Corp. SPAC merger, a high-risk signal for the de-SPAC market.
A notable sector theme is the concentrated insider buying in the biotech/pharma space, particularly at Quoin and Waste Energy, contrasting with routine insider selling for tax purposes at larger caps. Capital allocation is mixed, with Vertiv declaring a modest dividend while VolitionRx continues dilutive convertible note conversions. The Skyworks-Qorvo merger extension provides a key catalyst to monitor, while the HDFC Bank and ICICI Bank credit rating updates offer a positive signal for Indian financials. Overall, the data suggests a cautious market with selective, high-conviction bets in small-cap value and biotech, while large-cap tech and industrial insiders are reducing exposure.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: Form 4 · 8-K · Schedule 13G · Schedule 13D
Tracking the trend? Catch up on the prior US Pre-Market SEC Filings Roundup digest from August 26, 2026.
Investment Signals (10)
- Quoin Pharmaceuticals ↓ (BULLISH)▲
CEO, COO, CFO, and a Director collectively purchased ~$280K of ADSs at $4.88, a coordinated insider buying spree from the entire C-suite and board. This is a rare and powerful signal of extreme management conviction in the company's near-term prospects
- Coherent Corp ↓ (BEARISH)▲
CTO Eng Julie Sheridan sold $3.8M in stock via a 10b5-1 plan, while CEO Anderson had $3.53M withheld for taxes. The CTO's large sale, combined with multiple other executives selling for tax purposes, creates a negative overhang despite the stock's strength
- Standex International ↓ (BEARISH)▲
President/CEO/Chairman Dunbar sold $2.62M in stock via a 10b5-1 plan, a significant reduction in his personal stake. This is a strong bearish signal from the top executive at a diversified industrial company
- ICICI Bank ↓ (BULLISH)▲
Moody's and S&P assigned 'Baa3' and 'BBB' ratings to its $500M senior notes, a positive credit quality signal. This enhances the bank's access to international capital markets and reflects strong fundamentals
- Roivant Sciences ↓ (BEARISH)▲
President & Immunovant CEO Venker Eric sold $5.92M in stock after exercising options at $3.85, a classic 'sell-the-news' event. The large volume of sales relative to his holdings signals a potential top in the stock's near-term momentum
-
Extended the exchange offer deadline for Qorvo notes to Sept 11, indicating the merger is progressing but not yet finalized. The extension provides a clear catalyst date and suggests confidence in closing, but the delay introduces execution risk [NEUTRAL/BULLISH]
- Betterware de Mexico ↓ (BULLISH)▲
Controlling shareholder Campalier made open-market purchases of 75,762 shares at ~$16.50-$17.00, a vote of confidence despite a 51.36% controlling stake. This insider buying at a premium to recent levels signals value
- Lumentum Holdings ↓ (BEARISH)▲
President of Global Business Units Wupen Yuen sold $1.37M in stock across three trades at ~$895-$941, a consistent pattern of selling at high prices. This is a bearish signal from a key operational executive in a high-growth tech company
- Aviat Networks ↓ (BEARISH)▲
CEO Smith Pete A sold $281K in stock after receiving an award, a pattern of selling that aligns with other executives. While not massive, the consistent selling by the CEO and other officers creates a negative sentiment
- Waste Energy Corp ↓ (BULLISH)▲
Chairman/CEO/President Scott Gallagher purchased 400,000 shares at ~$0.0029, a massive increase in his stake using personal funds. This is a high-conviction insider buy at a distressed price, signaling a potential turnaround or undervaluation
Risk Flags (8)
-
The merger with SACH Pte. Ltd. was terminated due to the target's failure to cure defaults. This is a high-risk event that likely destroys SPAC value and signals potential liquidation, with the Purchaser Parties reserving rights to seek damages
- VolitionRx / Dilution Risk↓ [HIGH RISK]▼
Issued ~4.7 million shares (a significant portion of its float) to Lind Global to satisfy $1.725M in convertible note obligations. This multi-tranche conversion is highly dilutive to existing shareholders and signals ongoing financing stress
- Coherent Corp / Insider Selling Overhang↓ [MODERATE RISK]▼
Five separate insider filings show executives selling or having shares withheld for taxes at ~$295, with the CTO alone selling $3.8M. The concentrated selling at a high stock price creates a significant supply overhang and suggests insiders are taking profits
- Standex International / CEO Selling↓ [MODERATE RISK]▼
The CEO sold $2.62M in a single day via a 10b5-1 plan, representing a material reduction in his holdings. This is a clear risk flag for a company with a stable business model, as it suggests the CEO sees limited near-term upside
- Roivant Sciences / Large Insider Sale↓ [MODERATE RISK]▼
The President sold $5.92M in stock after exercising cheap options. This is a large, concentrated sale that could pressure the stock and signals a lack of confidence in near-term appreciation
- Aviat Networks / Consistent Insider Selling↓ [LOW RISK]▼
The CEO, SVP, and VP Legal all sold shares after receiving awards. This pattern of selling by multiple executives, even if small, is a negative signal for a company with a $19.69 stock price
- Oncology Institute / Board Departure↓ [LOW RISK]▼
Vice Chairman Brad Hively stepped down from his role and will not stand for re-election, effective immediately. While not a disagreement, the sudden departure of a key board member from a leadership role is a governance risk
- Super Hi International / Management Churn↓ [LOW RISK]▼
The company disclosed changes to its joint company secretary, authorized representative, and CFO. Multiple simultaneous changes in key corporate officer roles can signal instability or a strategic pivot
Opportunities (8)
- Quoin Pharmaceuticals / Insider Buying Spree↓ (OPPORTUNITY)◆
The entire C-suite and a director bought stock at $4.88, a rare and powerful signal. With a market cap likely under $50M, this coordinated buying suggests a near-term catalyst (e.g., trial data, partnership) that could drive significant upside
- Waste Energy Corp / Deep Value Insider Buy↓ (OPPORTUNITY)◆
The Chairman bought 400,000 shares at ~$0.0029, a massive vote of confidence in a distressed company. This is a high-risk/high-reward opportunity for investors willing to bet on a turnaround, as insider buying at such low levels is a strong signal
- Betterware de Mexico / Insider Accumulation↓ (OPPORTUNITY)◆
The controlling shareholder bought 75,762 shares at $16.41-$17.00, showing confidence post-Tupperware acquisition. The stock may be undervalued if the acquisition synergies materialize, and the insider buying provides a floor
- ICICI Bank / Credit Rating Upgrade↓ (OPPORTUNITY)◆
Moody's and S&P assigned investment-grade ratings to its new $500M notes. This positive credit event could lead to a re-rating of the bank's equity and lower its cost of capital, making it attractive for yield-oriented investors
- Skyworks Solutions / Merger Arbitrage↓ (OPPORTUNITY)◆
The exchange offer extension to Sept 11 provides a clear timeline for the Qorvo merger. Investors can play the arbitrage spread, with the extension suggesting confidence in closing, though the risk of delay remains
- Vertiv Holdings / Dividend Announcement↓ (OPPORTUNITY)◆
Declared a $0.0625 quarterly dividend, a sign of financial health and commitment to shareholder returns. This is a positive signal for income investors and could attract new institutional interest
- G Willi Food International / Passive Accumulation↓ (OPPORTUNITY)◆
Meitav Investment House disclosed a 16.50% passive stake, a significant institutional holding. This level of ownership by a major Israeli investment house suggests underlying value and provides a potential support level for the stock
- TAT Technologies / Institutional Interest↓ (OPPORTUNITY)◆
Two Israeli education fund managers disclosed a combined 6.25% stake. This passive investment by large, long-term-oriented funds signals confidence in the company's prospects and could lead to further accumulation
Sector Themes (6)
- Biotech/Pharma Insider Buying Surge (HIGH CONVICTION)◆
Quoin Pharmaceuticals (4 insiders buying) and Waste Energy (Chairman buying) show a clear pattern of insider buying in small-cap biotech/pharma. This suggests a sector-wide belief in undervaluation or impending catalysts, contrasting with the selling in larger-cap tech
- Tech/Industrial Insider Profit-Taking (CAUTIOUS)◆
Coherent, Standex, Lumentum, and Aviat all saw significant insider selling, primarily via 10b5-1 plans. This pattern indicates that insiders in high-growth tech and industrial sectors are taking profits at elevated valuations, a potential top signal for the sector
- De-SPAC Market Distress [RISK OFF]◆
The Quantumsphere merger termination is a stark reminder of the risks in the de-SPAC market. The failure to close a deal due to target defaults could lead to liquidation, highlighting the need for extreme caution in this space
- Indian Financials Credit Quality Improvement (POSITIVE)◆
ICICI Bank and HDFC Bank both filed positive updates, with ICICI receiving new credit ratings. This suggests a strengthening credit environment for Indian banks, making them attractive for emerging market exposure
- Capital Return vs. Dilution (DIVERGENT)◆
Vertiv initiated a dividend (positive), while VolitionRx continued dilutive financing (negative). This bifurcation shows a market where cash-rich companies are rewarding shareholders, while cash-poor companies are forced to dilute, a key differentiator for investors
- Foreign Issuer Passive Accumulation (BULLISH FOR SMALL CAPS)◆
Multiple filings from Israeli and Indian entities (Meitav, Kranot Hishtalmut) show passive institutional accumulation in small-cap foreign stocks. This suggests a trend of international institutional investors seeking value in smaller, overlooked markets
Watch List (8)
-
Exchange offer extended to Sept 11. Watch for any further delays or a successful close, which would be a major catalyst for Skyworks stock. The merger is key to Skyworks' growth strategy [Date: Sept 11, 2026]
-
The merger termination puts the SPAC on a path to liquidation. Watch for a shareholder vote on dissolution or a new target announcement. The stock price will likely trade near trust value [Date: Ongoing]
-
The coordinated insider buying at $4.88 is a strong signal. Watch for any press releases on clinical trial results, partnerships, or financing that could justify the insider conviction [Date: Near-term]
-
The company continues to issue shares to Lind Global. Watch for further conversions or a potential equity raise, which would further dilute shareholders. The stock price is a key indicator of market sentiment [Date: Ongoing]
-
With multiple executives selling at ~$295, watch for any acceleration in selling or a change in the 10b5-1 plan. A slowdown in selling could signal a bottom, while continued selling is a bearish indicator [Date: Ongoing]
-
The controlling shareholder's purchase post-acquisition is a positive sign. Watch for Q3 earnings to see if the Tupperware acquisition is accretive and if the insider buying continues [Date: Q3 2026 Earnings]
-
The CEO's purchase was disclosed via an 8-K due to EDGAR credential issues. Watch for the formal Form 4 filing, which will confirm the transaction and provide further details [Date: Near-term]
-
The CEO sold $2.62M in one day. Watch for any additional sales or a change in his 10b5-1 plan. If he continues to sell, it would be a strong negative signal for the stock [Date: Ongoing]
Filing Analyses
(50)
01-09-2026
President & Immunovant CEO Venker Eric sold 166,182 Common Shares at $35.63 (~$5.92M). 4 transactions reported in total. Venker Eric holds 1,599,154 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · President & Immunovant CEO Venker Eric exercised/converted 200,000 Common Shares at $3.85 (~$770K)
- · President & Immunovant CEO Venker Eric sold 166,182 Common Shares at $35.63 (~$5.92M)
- · President & Immunovant CEO Venker Eric sold 33,818 Common Shares at $36.44 (~$1.23M)
- · President & Immunovant CEO Venker Eric exercised/converted 200,000 Stock Option (Right to Buy)
01-09-2026
Chief Accounting Officer Jewell Renee Marie-Bentley was awarded 108,604 Class A Common Stock. Jewell Renee Marie-Bentley holds 108,604 shares after the transaction.
- · Chief Accounting Officer Jewell Renee Marie-Bentley was awarded 108,604 Class A Common Stock
01-09-2026
Interim CEO Benton Ryan A had withheld for taxes 10,093 Common Stock at $3.36 (~$33.9K). Benton Ryan A holds 903,523 shares after the transaction.
- · Interim CEO Benton Ryan A was awarded 19,060 Common Stock
- · Interim CEO Benton Ryan A had withheld for taxes 10,093 Common Stock at $3.36 (~$33.9K)
01-09-2026
Chief Accounting Officer Truong Kristina had withheld for taxes 6,626 Common Stock at $3.36 (~$22.3K). Truong Kristina holds 308,767 shares after the transaction.
- · Chief Accounting Officer Truong Kristina was awarded 12,512 Common Stock
- · Chief Accounting Officer Truong Kristina had withheld for taxes 6,626 Common Stock at $3.36 (~$22.3K)
01-09-2026
Chief Technology Officer Eng Julie Sheridan had withheld for taxes 12,862 Common Stock at $295.39 (~$3.8M). 5 transactions reported in total. Eng Julie Sheridan holds 41,027 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Chief Technology Officer Eng Julie Sheridan was awarded 5,373 Common Stock
- · Chief Technology Officer Eng Julie Sheridan was awarded 11,960 Common Stock
- · Chief Technology Officer Eng Julie Sheridan had withheld for taxes 12,862 Common Stock at $295.39 (~$3.8M)
- · Chief Technology Officer Eng Julie Sheridan sold 7,047 Common Stock at $276.83 (~$1.95M)
- · Chief Technology Officer Eng Julie Sheridan sold 6,030 Common Stock at $270.69 (~$1.63M)
01-09-2026
Chief Strategy & Legal Officer Beard Robert P had withheld for taxes 1,896 Common Stock at $295.39 (~$560K). Beard Robert P holds 51,928 shares after the transaction.
- · Chief Strategy & Legal Officer Beard Robert P was awarded 5,373 Common Stock
- · Chief Strategy & Legal Officer Beard Robert P had withheld for taxes 1,896 Common Stock at $295.39 (~$560K)
01-09-2026
CEO ANDERSON JAMES ROBERT had withheld for taxes 11,958 Common Stock at $295.39 (~$3.53M). ANDERSON JAMES ROBERT holds 185,287 shares after the transaction.
- · CEO ANDERSON JAMES ROBERT was awarded 30,564 Common Stock
- · CEO ANDERSON JAMES ROBERT had withheld for taxes 11,958 Common Stock at $295.39 (~$3.53M)
01-09-2026
President/CEO/Chairman Dunbar David A. sold 9,000 Common Stock at $290.82 (~$2.62M). Dunbar David A. holds 75,973 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · President/CEO/Chairman Dunbar David A. sold 4,000 Common Stock at $290.81 (~$1.16M)
- · President/CEO/Chairman Dunbar David A. sold 9,000 Common Stock at $290.82 (~$2.62M)
01-09-2026
Director Anderman David was awarded 165,829 Common Stock. Anderman David holds 189,054 shares after the transaction.
- · Director Anderman David was awarded 165,829 Common Stock
01-09-2026
PRESIDENT, GLOBAL BUS. UNITS Wupen Yuen sold 500 Common Stock at $940.95 (~$470K). Wupen Yuen holds 117,627 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · PRESIDENT, GLOBAL BUS. UNITS Wupen Yuen sold 500 Common Stock at $940.95 (~$470K)
- · PRESIDENT, GLOBAL BUS. UNITS Wupen Yuen sold 500 Common Stock at $895.00 (~$448K)
- · PRESIDENT, GLOBAL BUS. UNITS Wupen Yuen sold 500 Common Stock at $901.04 (~$451K)
01-09-2026
SVP of Product and Innovation Croke Gary sold 629 Common Stock at $19.69 (~$12.4K). Croke Gary holds 42,479 shares after the transaction.
- · SVP of Product and Innovation Croke Gary was awarded 1,208 Common Stock
- · SVP of Product and Innovation Croke Gary sold 629 Common Stock at $19.69 (~$12.4K)
01-09-2026
President and CEO SMITH PETE A sold 14,264 Common Stock at $19.69 (~$281K). SMITH PETE A holds 367,840 shares after the transaction.
- · President and CEO SMITH PETE A was awarded 23,357 Common Stock
- · President and CEO SMITH PETE A sold 14,264 Common Stock at $19.69 (~$281K)
01-09-2026
VP Legal Affairs Boase Erin sold 1,347 Common Stock at $19.69 (~$26.5K). Boase Erin holds 28,275 shares after the transaction.
- · VP Legal Affairs Boase Erin was awarded 3,826 Common Stock
- · VP Legal Affairs Boase Erin sold 1,347 Common Stock at $19.69 (~$26.5K)
01-09-2026
Chief Supply Chain Officer Place Jeffrey B. was awarded 3,358 Common Stock. Place Jeffrey B. holds 21,099 shares after the transaction.
- · Chief Supply Chain Officer Place Jeffrey B. was awarded 3,358 Common Stock
01-09-2026
Chief Marketing Officer Pestridge Simon James had withheld for taxes 3,679 Class C Common Stock. Pestridge Simon James holds 233,729 shares after the transaction.
- · Chief Marketing Officer Pestridge Simon James had withheld for taxes 3,679 Class C Common Stock
01-09-2026
Chief Accounting Officer Mocciaro Ilaria had withheld for taxes 2,174 Common Stock at $295.39 (~$642K). 4 transactions reported in total. Mocciaro Ilaria holds 24,154 shares after the transaction.
- · Chief Accounting Officer Mocciaro Ilaria was awarded 1,612 Common Stock
- · Chief Accounting Officer Mocciaro Ilaria was awarded 2,449 Common Stock
- · Chief Accounting Officer Mocciaro Ilaria had withheld for taxes 2,174 Common Stock at $295.39 (~$642K)
- · Chief Accounting Officer Mocciaro Ilaria was awarded 2,335 Deferred Performance Stock Units
01-09-2026
EVP, GC & Secretary Foster Mark E. sold 2,000 Common Stock at $55.39 (~$111K). Foster Mark E. holds 51,617 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · EVP, GC & Secretary Foster Mark E. sold 2,000 Common Stock at $55.39 (~$111K)
01-09-2026
CFO and Treasurer Luther Sherri R had withheld for taxes 2,594 Common Stock at $295.39 (~$766K). Luther Sherri R holds 70,855 shares after the transaction.
- · CFO and Treasurer Luther Sherri R was awarded 8,731 Common Stock
- · CFO and Treasurer Luther Sherri R had withheld for taxes 2,594 Common Stock at $295.39 (~$766K)
01-09-2026
Chief Operating Officer Carter Denise P. bought 20,490 ADSs at $4.88 (~$100K). Carter Denise P. holds 37,709 shares after the transaction.
- · Chief Operating Officer Carter Denise P. bought 20,490 ADSs at $4.88 (~$100K)
01-09-2026
Chief Executive Officer Myers Michael bought 20,490 ADSs at $4.88 (~$100K). Myers Michael holds 37,713 shares after the transaction.
- · Chief Executive Officer Myers Michael bought 20,490 ADSs at $4.88 (~$100K)
01-09-2026
Chief Financial Officer Lawlor Sally Bridget bought 10,244 ADSs at $4.88 (~$50K). Lawlor Sally Bridget holds 10,684 shares after the transaction.
- · Chief Financial Officer Lawlor Sally Bridget bought 10,244 ADSs at $4.88 (~$50K)
01-09-2026
Director Culverwell Anthony James bought 6,146 ADSs at $4.88 (~$30K). Culverwell Anthony James holds 40,364 shares after the transaction.
- · Director Culverwell Anthony James bought 6,146 ADSs at $4.88 (~$30K)
- · Director Culverwell Anthony James bought 3,073 Ordinary Warrants (Right to Buy)
01-09-2026
Director Polinsky David was awarded 5,083 Stock Option (Right to buy).
- · Director Polinsky David was awarded 5,083 Stock Option (Right to buy)
01-09-2026
CEO and Chairman Chesky Brian gifted 76,500 Class A Common Stock. Chesky Brian holds 10,425,185 shares after the transaction.
- · CEO and Chairman Chesky Brian gifted 76,500 Class A Common Stock
01-09-2026
Director Wexler William A. was awarded 5,943 Stock Option (Right to buy).
- · Director Wexler William A. was awarded 5,943 Stock Option (Right to buy)
01-09-2026
Director Ratner Elena was awarded 5,944 Stock Option (Right to buy).
- · Director Ratner Elena was awarded 5,944 Stock Option (Right to buy)
01-09-2026
President and CEO Luther Sanjeev was awarded 118,848 Stock Option (right to buy).
- · President and CEO Luther Sanjeev was awarded 118,848 Stock Option (right to buy)
01-09-2026
10% owner TAGLICH ROBERT bought 999 Common Stock at $5.52 (~$5.52K). TAGLICH ROBERT holds 455,338 shares after the transaction.
- · 10% owner TAGLICH ROBERT bought 1 Common Stock at $5.00 (~$5)
- · 10% owner TAGLICH ROBERT bought 999 Common Stock at $5.52 (~$5.52K)
01-09-2026
Director Bristol James Arthur was awarded 8,320 Stock Option (Right to buy).
- · Director Bristol James Arthur was awarded 8,320 Stock Option (Right to buy)
- · Director Bristol James Arthur was awarded 5,083 Stock Option (Right to buy)
01-09-2026
Director Cicala Peter was awarded 5,943 Stock Option (Right to buy).
- · Director Cicala Peter was awarded 5,943 Stock Option (Right to buy)
- · Director Cicala Peter was awarded 5,083 Stock Option (Right to buy)
02-09-2026
On September 1, 2026, Chairman, President, CEO and Interim CFO Scott Gallagher purchased 400,000 shares of Waste Energy Corp. common stock in open-market transactions using personal funds, at prices of $0.0029 and $0.0028 per share. The purchase increased his direct beneficial ownership from 1,305,714 shares to 1,705,714 shares. The company disclosed the insider purchase via an 8-K filing because Gallagher is still obtaining updated EDGAR filing credentials and intends to file a Form 4 promptly.
- · The purchase was made in open-market transactions using personal funds.
- · Gallagher is completing the process of obtaining updated EDGAR filing credentials and will file a Form 4 promptly.
- · The company has no securities registered under Section 12(b) of the Exchange Act (trading symbol N/A).
02-09-2026
HDFC Bank Limited filed a Form 6-K with the SEC for the month of September 2026, as a routine periodic report by a foreign private issuer. The filing contains no substantive financial or operational disclosures, only the standard cover page and signature block. The report was signed by Company Secretary Ajay Agarwal on September 1, 2026.
- · Filing is a Form 6-K for the month of September 2026.
- · Commission File Number: 001-15216.
- · Registrant address: HDFC Bank House, Senapati Bapat Marg, Lower Parel, Mumbai 400 013, India.
- · The registrant files annual reports under Form 20-F.
- · The report was signed on September 1, 2026.
02-09-2026
SK Telecom Co., Ltd. disclosed that officers and employees disposed of 1,061 common shares on August 31, 2026, at an aggregate disposal price of 99,946,200 Won (approximately $74,000 USD). Separately, the company reported direct acquisitions of 1,731,081 common shares (0.81% of total shares) valued at 86,937 million Won, with no acquisitions through brokers. The filing reflects routine insider transactions and shareholding updates with no material financial impact.
- · Disposal price per share was 94,200 Won.
- · No acquisitions were made through a broker (value and shares both zero).
- · Total direct acquisition value was 86,937 million Won.
02-09-2026
ICICI Bank disclosed provisional and unaudited data on its utilization of the RBI's swap facility for FCNR(B) deposits up to August 31, 2026. Gross mobilization under the facility was approximately USD 17.88 billion (₹1,702 billion), against which the Bank's international branches and subsidiaries provided loans of about USD 9.00 billion (₹856 billion) and standby letters of credit of about USD 3.63 billion (₹346 billion). Separately, the Bank issued approximately USD 3.55 billion (₹338 billion) in USD-denominated bonds during July-August 2026. The disclosure is routine regulatory reporting and does not contain any negative or flat performance metrics.
- · The disclosure is provisional and unaudited.
- · The Bank previously intimated the bond issuance on various dates.
- · ₹ amounts are convenience translations at the exchange rate prevailing on August 31, 2026.
02-09-2026
ICICI Bank Limited announced that Moody's Ratings and S&P Global Ratings have assigned 'Baa3' and 'BBB' ratings, respectively, to its USD 500 million Senior Unsecured Fixed Rate Notes issued under the bank's USD 7.5 billion Global Medium Term Note Programme. The ratings were assigned on September 1, 2026, and the notes are not offered or sold in the United States.
- · The ratings were assigned via letters dated September 1, 2026.
- · The notes are issued under the bank's USD 7.5 billion Global Medium Term Note Programme.
- · The notes are not registered under the U.S. Securities Act of 1933 and are not offered or sold in the United States.
02-09-2026
Vertiv Holdings Co declared a quarterly cash dividend of $0.0625 per share of Class A common stock, payable on September 24, 2026, to stockholders of record as of September 14, 2026. The dividend was announced via a press release on September 2, 2026, and is a routine capital return event with no negative or flat metrics reported.
- · Dividend record date: September 14, 2026
- · Dividend payment date: September 24, 2026
- · Press release attached as Exhibit 99.1
02-09-2026
United Microelectronics Corporation (UMC) filed a Form 6-K with the SEC on September 2, 2026, as a routine foreign issuer report. The filing was signed by CFO Chitung Liu and contains no financial results, material events, or operational updates beyond the administrative submission.
02-09-2026
Meitav Investment House Ltd filed an amended Schedule 13G disclosing aggregate beneficial ownership of 2,295,892 ordinary shares (16.50%) of G Willi Food International Ltd as of August 31, 2026. The filing is a routine disclosure of a passive investment by Meitav and its subsidiaries, with the filer certifying the securities were not acquired to influence control.
- · 21,431 ordinary shares (0.15%) held by Meitav Mutual Funds Ltd.
- · 2,274,461 ordinary shares (16.36%) held by Meitav Provident Funds & Pension Ltd.
- · Filer certifies passive investment intent; no group exists with other entities for control purposes.
02-09-2026
Zepp Health Corporation filed a Form 6-K with the SEC on September 2, 2026, reporting its unaudited financial results for the second quarter of 2026. The filing is signed by CFO Leon Deng and indicates the company will continue to file annual reports under Form 20-F. No specific financial figures or performance metrics are included in the filing itself, which only serves as a cover for the earnings release attached as Exhibit 99.1.
- · The filing is a Form 6-K for the month of September 2026
- · Commission File Number: 001-38369
- · Principal executive offices address: Edisonweg 44 – B08, 4207 HG Gorinchem, The Netherlands
- · The company indicates it files annual reports under Form 20-F (not Form 40-F)
- · Exhibit 99.1 contains the full unaudited Q2 2026 financial results press release
02-09-2026
BW LPG Ltd disclosed the key terms of a bond offering, conducted concurrently with a placement of existing shares (the 'Concurrent Delta Placement') by certain bond subscribers to hedge market risk. The company received no proceeds from the share placement, which is a routine capital markets transaction.
- · The bond offering was conducted concurrently with the Concurrent Delta Placement.
- · The sole placement agent conducted the share placement on behalf of certain bond subscribers.
- · The share placement was used by subscribers to hedge market risk related to the bonds.
- · BW LPG received no proceeds from the Concurrent Delta Placement.
02-09-2026
Two Israeli education fund management companies, Kranot Hishtalmut Le Morim Ve Gananot Hevera Menahelet Ltd. and Kranot Hishtalmut Le Morim Tichoniim Hevera Menahelet Ltd., filed a Schedule 13G disclosing combined beneficial ownership of 811,583 ordinary shares of TAT Technologies Ltd., representing 6.25% of shares outstanding as of August 24, 2026. The filing is a passive investment disclosure under Rule 13d-1(c), with the filers disclaiming beneficial ownership and stating the shares are held for the benefit of education fund members. No negative or declining metrics are present; the filing reflects a routine ownership disclosure.
- · The filing is made under Rule 13d-1(c), indicating passive investment intent.
- · The reporting persons disclaim beneficial ownership of the securities.
- · The securities are held for the benefit of members of education funds managed by the reporting companies.
- · The management companies operate independently and make independent voting and investment decisions.
- · The filing includes a Joint Filing Agreement dated September 2, 2026.
02-09-2026
Woodside Energy Group Ltd filed a Form 6-K with the SEC on September 2, 2026, attaching an ASX announcement titled 'Appendix 3Y (Non-Executive Directors)'. The filing is a routine foreign private issuer report disclosing changes in director interests, with no financial results or material operational updates.
- · The filing is a Form 6-K for the month of September 2026.
- · The attached ASX announcement is dated September 2, 2026, and relates to non-executive directors.
- · The registrant's principal executive offices are at Mia Yellagonga, 11 Mount Street, Perth, Western Australia 6000.
02-09-2026
Alterity Therapeutics Ltd filed a Form 6-K with the SEC for September 2026, primarily to disclose a change in a director's interest notice related to Stamler. The filing also incorporates this report by reference into several of the company's existing registration statements. No financial results or operational updates were provided.
- · The filing incorporates this Form 6-K by reference into Registration Statements on Form S-8 (Nos. 333-251073, 333-248980, 333-228671) and Form F-3 (Nos. 333-274816, 333-251647, 333-231417, 333-250076).
- · The company is described as a 'development stage enterprise'.
02-09-2026
Campalier, S.A. de C.V. and Luis German Campos Orozco filed Amendment No. 2 to their Schedule 13D, disclosing beneficial ownership of 20,278,497 ordinary shares (51.36%) of Betterware de Mexico. The filing notes that the percentage decreased from the prior filing due to share dilution from the Tupperware Acquisition, not from any sales by the Reporting Persons. In the past 60 days, Campalier made open-market purchases totaling 75,762 shares at weighted-average prices between $16.411 and $17.00.
- · On July 6, 2026, a trust holding 19,597,829 shares beneficially owned by Mr. Campos was dissolved, and all shares reverted to Campalier with no consideration paid.
- · The Tupperware Acquisition closed on June 2, 2026, resulting in the issuance of 2,241,133 new ordinary shares.
- · The decrease in ownership percentage is solely due to dilution from the Tupperware Acquisition, not from any sale by the Reporting Persons.
02-09-2026
Alterity Therapeutics Ltd filed a Form 6-K with the SEC for September 2026, primarily to submit a Change of Director's Interest Notice for director Marks. The filing also incorporates the report by reference into several existing SEC registration statements. No financial results or operational updates were provided.
- · The filing incorporates the report by reference into Registration Statements on Form S-8 (File Nos. 333-251073, 333-248980, 333-228671) and Form F-3 (File Nos. 333-274816, 333-251647, 333-231417, 333-250076).
- · The company is described as a development stage enterprise.
02-09-2026
Super Hi International Holding Ltd. filed a Form 6-K with the SEC on September 2, 2026, disclosing changes to its joint company secretary, authorized representative, and chief financial officer, along with a waiver from strict compliance with Listing Rules 3.28 and 8.17. The filing is a routine corporate governance update and contains no financial figures.
- · Change of Joint Company Secretary, Authorized Representative and Chief Financial Officer
- · Waiver from strict compliance with Listing Rules 3.28 and 8.17
02-09-2026
VolitionRx Ltd issued approximately 4.7 million shares of common stock to Lind Global Asset Management XII LLC in seven separate transactions between August 27 and August 31, 2026, to satisfy aggregate conversion obligations of approximately $1.725 million under existing senior secured convertible promissory notes. The shares were issued without registration, relying on exemptions under Section 3(a)(9), Section 4(a)(2), and Rule 506 of Regulation D. This multi-tranche conversion underscores ongoing financing through Lind while reflecting potential dilution for existing shareholders.
- · Total shares issued across all seven tranches: approximately 4,698,628 shares.
- · Aggregate conversion obligations satisfied in this period: $1,725,000.
- · The shares were issued under exemptions including Section 3(a)(9), Section 4(a)(2), and Rule 506 of Regulation D.
- · No paid commissions were involved in these issuances.
- · The original promissory notes were issued under a securities purchase agreement dated May 15, 2025 (as amended and restated on January 7, 2026).
02-09-2026
On September 1, 2026, Brad Hively notified Starling Oncology, Inc. (formerly The Oncology Institute, Inc.) of his decision not to stand for re-election to the Board at the 2027 annual meeting. He will continue as a director until the meeting but immediately stepped down as Vice Chairman and from the Compliance Committee. The departure is not due to any disagreement with the company.
- · Brad Hively will continue to serve as a director until the 2027 annual meeting of stockholders.
- · Effective immediately, he is no longer Vice Chairman of the Board or a member of the Compliance Committee or any other Board committees.
- · The decision is not the result of any disagreement with the company regarding operations, policies, or practices.
02-09-2026
Quantumsphere Acquisition Corp terminated its Agreement and Plan of Merger with SACH Pte. Ltd., originally dated October 3, 2025, due to the target company's failure to cure defaults within the required 30-day period following a Notice of Default issued on July 14, 2026. The Purchaser Parties reserve all rights to seek damages and other legal relief. This termination likely ends the proposed business combination, potentially impacting the SPAC's ability to complete a de-SPAC transaction.
- · Merger Agreement dated October 3, 2025
- · Notice of Default issued July 14, 2026
- · 30-day cure period expired without remedy
- · Termination effective September 1, 2026
- · Purchaser Parties reserve rights to seek damages, costs, expenses, and other legal/equitable relief
02-09-2026
Skyworks Solutions extended the expiration date of its exchange offers for Qorvo's outstanding 4.375% Senior Notes due 2029 and 3.375% Senior Notes due 2031 from September 1, 2026 to September 11, 2026. The exchange offers are part of Skyworks' pending merger with Qorvo, which Skyworks hopes to close within the calendar year and is preparing to close as early as within the fiscal year. However, the company cautioned that there can be no assurances the closing will occur on this timeline, and all other terms and conditions of the exchange offers remain unchanged.
- · The exchange offers were previously scheduled to expire at 5:00 p.m., New York City time, on September 1, 2026.
- · The new expiration date is 5:00 p.m., New York City time, on September 11, 2026.
- · The registration statement on Form S-4 was declared effective on May 29, 2026.
- · Any further extension of the Expiration Date will be announced by press release and may not be accompanied by an additional Form 8-K.
Get daily alerts with 10 investment signals, 8 risk alerts, 8 opportunities and full AI analysis of all 50 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: US Pre-Market SEC Filings Roundup
🇺🇸 More from United States
View all →August 25, 2026
US SEC Filings Daily Market Digest — August 25, 2026
US SEC Filings Daily Market Digest
August 25, 2026
S&P 500 Energy Sector SEC Filings — August 25, 2026
S&P 500 Energy Sector SEC Filings
August 25, 2026
New Drug Approvals (Original) — August 25, 2026
New Drug Approvals (Original)
August 25, 2026
Orphan Drug Approvals — August 25, 2026
Orphan Drug Approvals